Prevalence, risk and severity of SARS-CoV-2 infections in psoriasis patients receiving conventional systemic, biologic or topical treatment during the COVID-19 pandemic: a cross-se... by Kevin V. Kwee, Jean-Luc Murk, Qiqi Yin, M. Birgitte Visch, Linda Davidson, Elke M. G. J. de Jong, Juul M. P. A. van den Reek, Milan Tjioe

Get full text

Safety Assessment of Conventional and Biological Systemic Therapy in Older Adults with Psoriasis, a Real-world Multicentre Cohort Study by Elke L.M. ter Haar, Eline E. ten Bruin, Ewald E. Bronkhorst, Rinke J. Borgonjen, Marloes M. Kleinpenning, Else N. Kop, M. Birgitte Visch, Peter C.M. van de Kerkhof, Elke M.G.J. de Jong, Satish F.K. Lubeek

Get full text

Risk of respiratory tract infections and serious infections in psoriasis patients treated with biologics: Results from the BioCAPTURE registry by Lara S. van derSchoot, Hans J. M. M. Groenewoud, Marleen M. H. J. vanGelder, Marisol E. Otero, W. Peter Arnold, Maartje A. M. Berends, Marjolein S. De Bruin‐Weller, Sharon R. P. Dodemont, Marloes M. Kleinpenning, Marjolein I. A. Koetsier, Else N. Kop, John E. M. Körver, Astrid L. A. Kuijpers, Paula P. vanLümig, Johannes M. Mommers, Marcellus D. Njoo, Paul M. Ossenkoppele, Ron A. Tupker, M. Birgitte Visch, Lizelotte J. M. T. Weppner‐Parren, Elke M. G. J. deJong, Juul M. P. A. van denReek

Get full text